More than 100 reimbursed generics of Xarelto will be pouring into the market next month with the substance patent expiry of the novel oral anticoagulant (NOAC) Xarelto (rivaroxaban).

Among the drugs, products that are subject to premium pricing for being drugs from innovative pharmaceutical companies, etc. are Chong Kun Dang’s Riroxia Tab. 15mg, and 20mg that was released earlier in May. The two drugs will receive premium pricing for 7 months based on the release date of the 20mg strength.

According to industry sources on the 23rd, the Ministry of Health and Welfare is working to amend the ‘Drug reimbursement list and reimbursement ceiling price table’ to include such changes. The ch